Murray Stahl’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Murray Stahl’s Portfolio ARNA Stock Details ARNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-4,500	Closed	-$418K	–	359
2021 Q4	$418K	Hold	4,500	–	–	0.01%	260
2021 Q3	$268K	Hold	4,500	–	–	0.01%	300
2021 Q2	$307K	Hold	4,500	–	–	0.01%	295
2021 Q1	$312K	Hold	4,500	–	–	0.01%	286
2020 Q4	$346K	Hold	4,500	–	–	0.01%	274
2020 Q3	$337K	Hold	4,500	–	–	0.01%	280
2020 Q2	$283K	Buy	+4,500	New	+$248K	0.01%	297
2020 Q1	–	Sell	-4,500	Closed	-$204K	–	487
2019 Q4	$204K	Hold	4,500	–	–	0.01%	457
2019 Q3	$206K	Hold	4,500	–	–	0.01%	455
2019 Q2	$264K	Hold	4,500	–	–	0.01%	429
2019 Q1	$202K	Buy	+4,500	New	+$206K	0.01%	456

Murray Stahl's ARNA Position: Q1 2022 in Review

Murray Stahl sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2022, closing a stake of 4,500 shares — an estimated $418K sold.

Murray Stahl first reported a position in ARNA in Q1 2019 and held it in 11 quarters. The position peaked at $418K in Q4 2021. 1 fund tracked by Wall St. Rank holds ARNA as of Q1 2022.

Murray Stahl reported no remaining Arena Pharmaceuticals Inc position as of Q1 2022 after selling out during the quarter.
Murray Stahl sold 4,500 Arena Pharmaceuticals Inc shares in Q1 2022, an estimated $418K.
Murray Stahl first reported a position in Arena Pharmaceuticals Inc in Q1 2019 and held it in 11 quarters.
Murray Stahl's Arena Pharmaceuticals Inc position peaked at $418K in Q4 2021.
1 fund tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2022.

Based on Horizon Kinetics Asset Management's 13F filing for Q1 2022, filed 13 May 2022.